671 related articles for article (PubMed ID: 1082003)
1. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
Sultan Y; Simeon J; Caen JP
J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
[TBL] [Abstract][Full Text] [Related]
2. Immunologic studies in von Willebrand's disease: alteration of factor VIII/von Willebrand protein after transfusion with plasma concentrates in patients with von Willebrand's disease.
Sultan Y; Simeon J; Maisonneuve P; Caen JP
Thromb Haemost; 1976 Feb; 35(1):110-9. PubMed ID: 1085498
[TBL] [Abstract][Full Text] [Related]
3. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
Weiss HJ; Sussman II; Hoyer LW
J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
[TBL] [Abstract][Full Text] [Related]
4. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
Gralnick HR; Coller BS; Sultan Y
J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
6. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
7. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
[TBL] [Abstract][Full Text] [Related]
9. Von Willebrand's disease with spontaneous platelet aggregation induced by an abnormal plasma von Willebrand factor.
Grainick HR; Williams SB; McKeown LP; Rick ME; Maisonneuve P; Jenneau C; Sultan Y
J Clin Invest; 1985 Oct; 76(4):1522-9. PubMed ID: 2932469
[TBL] [Abstract][Full Text] [Related]
10. Carbohydrate of the factor VIII/von Willebrand factor in von Willebrand's disease.
Zimmerman TS; Voss R; Edgington TS
J Clin Invest; 1979 Nov; 64(5):1298-302. PubMed ID: 315413
[TBL] [Abstract][Full Text] [Related]
11. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
[TBL] [Abstract][Full Text] [Related]
12. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
McCarroll DR; Ruggeri ZM; Montgomery RR
J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
[TBL] [Abstract][Full Text] [Related]
13. [Diagnosis of von Willebrand's disease].
Baklaja R; Stojimirović E; Kezić J; Cuperlović K; Jovanović B; Cvetković V; Rasović N; Stajić M
Bilt Hematol Transfuz; 1977; 5(3-4):41-61. PubMed ID: 307953
[TBL] [Abstract][Full Text] [Related]
14. The effects of epinephrine infusion in patients with von Willebrand's disease.
Rickles FR; Hoyer LW; Rick ME; Ahr DJ
J Clin Invest; 1976 Jun; 57(6):1618-25. PubMed ID: 1084352
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of von Willebrand's disease: study of 40 Iranian cases.
Shoa'i I; Lavergne JM; Ardaillou N; Obert B; Ala F; Meyer D
Br J Haematol; 1977 Sep; 37(1):67-83. PubMed ID: 303911
[TBL] [Abstract][Full Text] [Related]
17. von Willebrand's disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand's disease.
Montgomery RR; Zimmerman TS
J Clin Invest; 1978 Jun; 61(6):1498-507. PubMed ID: 307007
[TBL] [Abstract][Full Text] [Related]
18. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
19. [Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of Von Willerbrand's disease (author's transl)].
Mazurier C; Parquet-Gernez A; Goudemand M
Pathol Biol (Paris); 1977 Dec; 25 Suppl():18-24. PubMed ID: 353655
[TBL] [Abstract][Full Text] [Related]
20. Abnormal antigenic reactivity of factor VIII/von Willebrand factor subunit in variants of von Willebrand's disease.
Girma JP; Pietu G; Lavergne JM; Meyer D; Larrieu MJ
J Lab Clin Med; 1982 Apr; 99(4):481-94. PubMed ID: 6174657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
